Drug Evaluation Committee Manual for Notification of "Electronic Annexes of Drugs for Prescription Use" (August 2021 edition)
August 2021
Since the computerization of accompanying documentation under the revised Pharmaceutical Affairs Law came into effect on August 1, 2021, the Drug Evaluation Committee's PV Subcommittee Continuing Issues Team 4 has prepared a "Notification Manual for Electronic Attached Documents for Prescription Drugs (August 2021 Edition)" in response to the revised law.
This document was prepared based on information as of July 30, 2021. Please note that the contents of this document may be subject to change due to notices, etc., to be issued in the future.
Japan Pharmaceutical Manufacturers Association Drug Evaluation Committee
PV Subcommittee Continuing Issues Team 4